Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Key Drivers
3.1.1. Growing Stress And Lifestyle Disorders
3.1.2. Increased Age Of Conception
3.1.3. Increasing Effectiveness Of Treatments
3.1.4. Rising Government Support
3.2. Key Restraints
3.2.1. High Cost Of Testing And Treatment
3.2.2. Infertility Considered A Social Taboo
3.2.3. Possible Risks Associated With Infertility Treatments

4. Key Analytics
4.1. Impact Of Covid-19 On Infertility Testing & Treatment Market
4.2. Key Market Trends
4.3. Porter’S Five Forces Analysis
4.3.1. Buyers Power
4.3.2. Suppliers Power
4.3.3. Substitution
4.3.4. New Entrants
4.3.5. Industry Rivalry
4.4. Opportunity Matrix
4.5. Vendor Landscape
4.6. Key Buying Criteria
4.6.1. Treatment Options
4.6.2. Quality Of Medical Procedures
4.6.3. Price Of Treatments
4.6.4. Shift Towards Medical Tourism
4.6.5. Reimbursement
4.7. Regulatory Framework
4.8. Value Chain Analysis
4.8.1. Raw Material Procurement
4.8.2. Manufacturing
4.8.3. Supply Logistics
4.8.4. Distribution Channels
4.8.5. End-Users

5. Market By Gender
5.1. Male
5.1.1. Male Infertility Testing
5.1.1.1. Dna Fragmentation
5.1.1.2. Oxidative Stress Analysis
5.1.1.3. Sperm Penetration Assay
5.1.1.4. Computer-Assisted Semen Analysis (Casa)
5.1.1.5. Sperm Agglutination
5.1.1.6. Microscopic Examination
5.1.1.7. Others
5.1.2. Male Infertility Treatment
5.1.2.1. Medication
5.1.2.2. Assisted Reproductive Technology & Varicocele Surgery
5.2. Female
5.2.1. Female Infertility Testing
5.2.1.1. Ovulation Testing
5.2.1.2. Hysterosalpingography
5.2.1.3. Laparoscopy
5.2.1.4. Transvaginal Ultrasound
5.2.1.5. Ovarian Reserve Testing
5.2.1.6. Hormonal Level Testing
5.2.1.7. Others
5.2.2. Female Infertility Treatment
5.2.2.1. Ivf With Icsi
5.2.2.2. Iui
5.2.2.3. Ivf Without Icsi
5.2.2.4. Surrogacy
5.2.2.5. Others

6. Market By End-User
6.1. Fertility And Surgical Centers
6.2. Hospitals And Research Laboratories
6.3. Cryobanks

7. Geographical Analysis
7.1. North America
7.1.1. Key Growth Enablers
7.1.2. Key Challenges
7.1.3. Key Players
7.1.4. Country Analysis
7.1.4.1. United States
7.1.4.2. Canada

8. Competitive Landscape
8.1. Key Strategic Developments
8.1.1. Mergers & Acquisitions
8.1.2. Product Launches & Developments
8.1.3. Partnerships & Agreements
8.2. Company Profiles
8.2.1. Adorfem
8.2.2. Bangkok Ivf Center
8.2.3. Cook Medical Inc
8.2.4. Cooper Surgical
8.2.5. Create Fertility Centre
8.2.6. Emd Group (Merck Kgaa)
8.2.7. Endo International Plc
8.2.8. Esco Medical
8.2.9. Ferring Pharmaceuticals
8.2.10. Fertility First
8.2.11. Fujifilm Irvine Scientific
8.2.12. Genea Ltd
8.2.13. Halotech Dna
8.2.14. Hamilton Throne Ltd
8.2.15. Ivftech
8.2.16. Labotect Gmbh
8.2.17. Olympus Corporation
8.2.18. Progyny
8.2.19. Thermo Fisher Scientific Inc
8.2.20. Vitrolife Ab



List of Figures

List Of Figures
Figure 1: Key Market Trends
Figure 2: Porter’S Five Forces Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: Key Buying Criteria
Figure 6: Value Chain Analysis
Figure 7: North America Infertility Testing & Treatment Market, Growth Potential, By Gender, In 2020
Figure 8: North America Infertility Testing & Treatment Market, By Male, 2021-2028 (In $ Million)
Figure 9: North America Infertility Testing & Treatment Market, Growth Potential, By Male, In 2020
Figure 10: North America Infertility Testing & Treatment Market, By Male Infertility Testing, 2021-2028 (In $ Million)
Figure 11: North America Infertility Testing & Treatment Market, Growth Potential, By Male Infertility Testing, In 2020
Figure 12: North America Infertility Testing & Treatment Market, By Dna Fragmentation, 2021-2028 (In $ Million)
Figure 13: Causes Of Sperm Dna Fragmentation
Figure 14: North America Infertility Testing & Treatment Market, By Oxidative Stress Analysis, 2021-2028 (In $ Million)
Figure 15: North America Infertility Testing & Treatment Market, By Sperm Penetration Assay, 2021-2028 (In $ Million)
Figure 16: North America Infertility Testing & Treatment Market, By Computer-Assisted Semen Analysis (Casa), 2021-2028 (In $ Million)
Figure 17: North America Infertility Testing & Treatment Market, By Sperm Agglutination, 2021-2028 (In $ Million)
Figure 18: North America Infertility Testing & Treatment Market, By Microscopic Examination, 2021-2028 (In $ Million)
Figure 19: North America Infertility Testing & Treatment Market, By Others, 2021-2028 (In $ Million)
Figure 20: North America Infertility Testing & Treatment Market, By Male Infertility Treatment, 2021-2028 (In $ Million)
Figure 21: North America Infertility Testing & Treatment Market, Growth Potential, By Male Infertility Testing, In 2020
Figure 22: North America Infertility Testing & Treatment Market, By Medication, 2021-2028 (In $ Million)
Figure 23: North America Infertility Testing & Treatment Market, By Assisted Reproductive Technology & Varicocele Surgery, 2021-2028 (In $ Million)
Figure 24: North America Infertility Testing & Treatment Market, By Female, 2021-2028 (In $ Million)
Figure 25: North America Infertility Testing & Treatment Market, Growth Potential, By Female, In 2020
Figure 26: North America Infertility Testing & Treatment Market, By Female Infertility Testing, 2021-2028 (In $ Million)
Figure 27: North America Infertility Testing & Treatment Market, Growth Potential, By Female Infertility Testing, In 2020
Figure 28: North America Infertility Testing & Treatment Market, By Ovulation Testing, 2021-2028 (In $ Million)
Figure 29: North America Infertility Testing & Treatment Market, By Hysterosalpingography, 2021-2028 (In $ Million)
Figure 30: North America Infertility Testing & Treatment Market, By Laparoscopy, 2021-2028 (In $ Million)
Figure 31: North America Infertility Testing & Treatment Market, By Transvaginal Ultrasound, 2021-2028 (In $ Million)
Figure 32: North America Infertility Testing & Treatment Market, By Ovarian Reserve Testing, 2021-2028 (In $ Million)
Figure 33: North America Infertility Testing & Treatment Market, By Hormonal Level Testing, 2021-2028 (In $ Million)
Figure 34: North America Infertility Testing & Treatment Market, By Others, 2021-2028 (In $ Million)
Figure 35: North America Infertility Testing & Treatment Market, By Female Infertility Treatment, 2021-2028 (In $ Million)
Figure 36: North America Infertility Testing & Treatment Market, Growth Potential, By Female Infertility Treatment, In 2020
Figure 37: North America Infertility Testing & Treatment Market, By Ivf With Icsi, 2021-2028 (In $ Million)
Figure 38: North America Infertility Testing & Treatment Market, By Iui, 2021-2028 (In $ Million)
Figure 39: North America Infertility Testing & Treatment Market, By Ivf Without Icsi, 2021-2028 (In $ Million)
Figure 40: North America Infertility Testing & Treatment Market, By Surrogacy, 2021-2028 (In $ Million)
Figure 41: North America Infertility Testing & Treatment Market, By Others, 2021-2028 (In $ Million)
Figure 42: North America Infertility Testing & Treatment Market, Growth Potential, By End-User, In 2020
Figure 43: North America Infertility Testing & Treatment Market, By Fertility And Surgical Centers, 2021-2028 (In $ Million)
Figure 44: North America Infertility Testing & Treatment Market, By Hospitals And Research Laboratories, 2021-2028 (In $ Million)
Figure 45: North America Infertility Testing & Treatment Market, By Cryobanks, 2021-2028 (In $ Million)
Figure 46: North America Infertility Testing & Treatment Market, Regional Outlook, 2020 & 2028 (In %)
Figure 47: United States Infertility Testing & Treatment Market, 2021-2028 (In $ Million)
Figure 48: Canada Infertility Testing & Treatment Market, 2021-2028 (In $ Million)

List of Tables

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - INFERTILITY TESTING & TREATMENT
TABLE 2: AVERAGE COST COMPARISON OF INFERTILITY TREATMENTS
TABLE 3: REGULATORY FRAMEWORK
TABLE 4: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY GENDER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: PROS AND CONS OF DNA SHARING METHODS
TABLE 11: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 12: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY MALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 13: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 14: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 15: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 16: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TESTING, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 17: COST OF OVULATION TESTING KITS IN THE US
TABLE 18: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 19: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY FEMALE INFERTILITY TREATMENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 20: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 21: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 22: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 23: NORTH AMERICA INFERTILITY TESTING & TREATMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 24: LIST OF MERGERS & ACQUISITIONS
TABLE 25: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 26: LIST OF PARTNERSHIPS & AGREEMENTS